AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2005
Jan 10, 2005
34152_dirs_2005-01-10_3794ad7d-f601-4f60-ace7-321e899e2bbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-01-06
Reporting Person: ELAN CORP PLC (10% Owner)
Reporting Person: ELAN INTERNATIONAL SERVICES LTD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-01-06 | Common Stock | S | 43600 | $1.75 | Disposed | 11626282 | Indirect |
Footnotes
F1: These securities are or were beneficially owned indirectly by Elan Corporation, plc ("Elan") and directly by its wholly-owned
subsidiary, Elan International Services, Ltd. ("EIS").
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23